In development: Guidance, quality standards and advice
Showing 11 to 11 of 11
Title | Type | Expected publication date |
---|---|---|
Venetoclax with dexamethasone for treating relapsed or refractory t(11;14)-positive multiple myeloma after lenalidomide and a proteasome inhibitor [ID4040] | Technology appraisal guidance | TBC |